Article Text

Download PDFPDF
Letter
National survey of the use of intraoperative antibiotics for prophylaxis against postoperative endophthalmitis following cataract surgery in the UK
  1. S Murjaneh1,
  2. S Waqar1,
  3. J E Hale2,
  4. M Kasmiya1,
  5. J Jacob1,
  6. A G Quinn1
  1. 1West of England Eye Unit, Exeter, UK
  2. 2Bristol Eye Hospital, Bristol, UK
  1. Correspondence to Dr Anthony G Quinn, West of England Eye Unit, Royal Devon and Exeter (Wonford) Hospital, Barrack Road, Exeter, Devon EX2 5DW, UK; anthony.quinn{at}rdeft.nhs.uk

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Postoperative endophthalmitis (POE) is a serious complication after cataract surgery. The rate of endophthalmitis was reported in the British Ophthalmological Surveillance Unit (BOSU) study as 1/700 (0.14%) cataract operations.1 With regard to the peri-operative use of antibiotics, the BOSU recommended the use of subconjunctival cefuroxime.2 A Swedish national prospective survey reported POE in 0.053% of units that used intracameral antibiotics as a standard protocol. Of these units, 98.5% used intracameral cefuroxime.3

The European Society of Cataract and Refractive Surgeons (ESCRS) Endophthalmitis Study Group recommended the use of intracameral cefuroxime in 1 mg/0.1 ml normal saline and reported a POE rate of 0.06% in patients who had intracameral cefuroxime.4 The Royal College of Ophthalmologists professional guidance, updated June 2007, recommended considering the use of intracameral cefuroxime.

Three years following the ESCRS recommendations, we conducted a national survey to identify the level of application of ESCRS recommendations …

View Full Text

Footnotes

  • Competing interests None.

  • Provenance and peer review Not commissioned; not externally peer reviewed.